Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3011878

CCOCCOC1CCNC1.[Cl-].[H+]

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ CHRM1 known ✓ P11229 3/20 0.42
▸ CHRM2 known ✓ P08172 2/20 0.42
▸ CHRM3 known ✓ P20309 2/20 0.42
▸ SLC6A2 known ✓ P23975 5/20 0.35
▸ SLC6A3 known ✓ Q01959 5/20 0.35
▸ KCNH2 Q12809 5/20 0.35
▸ SLC6A4 P31645 5/20 0.35
▸ EPHX2 P34913 1/20 0.33
▸ CHRNB2 P17787 2/20 0.31
▸ CHRNA4 P43681 2/20 0.31
▸ CYP2D6 P10635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2555634 0.96 CHRM1 (0.41) CHRM1CHRM2CHRM3KCNH2SLC6A2
Hydrochloric Acid SCHEMBL3011881 0.95 CHRM1 (0.40) CHRM1CHRM2CHRM3KCNH2SLC6A2
SCHEMBL19959125 0.86 CHRNB2 (0.39) CHRM1CHRM2CHRM3SLC6A2SLC6A4
SCHEMBL1317639 0.85 EPHX2 (0.38) SLC6A2SLC6A4SLC6A3EPHX2CYP2D6
SCHEMBL27364707 0.83 EPHX2 (0.40) SLC6A2SLC6A4SLC6A3EPHX2CYP2D6
SCHEMBL17309259 0.80 CHRM1 (0.36) CHRM1CHRM2CHRM3KCNH2SLC6A2
SCHEMBL17765041 0.80 CHRM1 (0.36) CHRM1CHRM2CHRM3KCNH2SLC6A2
SCHEMBL16333287 0.80 CHRM1 (0.36) CHRM1CHRM2CHRM3KCNH2SLC6A2
SCHEMBL21469059 0.80 CHRM1 (0.36) CHRM1CHRM2CHRM3KCNH2SLC6A2
SCHEMBL17293853 0.80 CHRM1 (0.36) CHRM1CHRM2CHRM3KCNH2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2152664-B1 DIPEPTIDE ANALOGS AS COAGULATION FACTOR INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2014-09-03 — — EP disclosed
US-8367709-B2 Dipeptide analogs as coagulation factor inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2013-02-05 — — US disclosed
US-20100173899-A1 DIPEPTIDE ANALOGS AS COAGULATION FACTOR INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2010-07-08 — — US disclosed
EP-2152664-A1 DIPEPTIDE ANALOGS AS COAGULATION FACTOR INHIBITORS Brystol-Myers Squibb Company (US) 2010-02-17 — — EP disclosed
WO-2008157162-A1 DIPEPTIDE ANALOGS AS COAGULATION FACTOR INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-12-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173899-A1 DIPEPTIDE ANALOGS AS COAGULATION FACTOR INHIBITORS F11, TFPI, SERPINC1 CHRM1 4844/4885CHRM2 4846/4885CHRM3 4792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback